Bayer AG

Germany Country flag Germany
Sector: Specialty Chemicals
Ticker: BAYN
ISIN: DE000BAY0017
Factsheet Factsheet

Market multiple valuation of Bayer AG ( BAYN | DEU)

The most common multiple used in the valuation of stocks is the P/Earnings NTM multiple (Price to Earnings). P/E relates the current share price with the market expectations in terms of Earnings Per Share. This multiple is used to compare a company's market value with its earnings. A company with a high P/Earnings NTM is considered to be overvalued; a company with a low P/Earnings NTM is considered to be undervalued.
The P/Earnings NTM ratio of Bayer AG is significantly lower than the median of its peer group: around 13.00. The company valuation of Bayer AG according to these metrics is way below the market valuation of its peer group.
The P/Earnings NTM ratio of Bayer AG is significantly lower than the average of its sector (Specialty Chemicals): 11.46. The company valuation of Bayer AG according to these metrics is way below the market valuation of its sector.
The P/Earnings NTM ratio of Bayer AG is significantly lower than its historical 5-year average: 7.0. The (current) company valuation of Bayer AG is therefore way below its valuation average over the last five years.

Valuation
P/E Last P/E (e) 2025P/E NTM
Bayer AGFree trialFree trialFree trial
International PeersFree trialFree trialFree trial
Specialty Chemicals13.2211.9811.46
DAX 4016.8914.2113.97
Germany10.2612.1011.66
More...
Beta (Ref: DAX 40)
Levered betaUnlevered beta
1-Year0.670.17
2-Year0.950.24
3-Year0.730.18
More...
Stock Perf excl. Dividends (in EUR)
BAYNDAX 40Rel. Perf.
Year-to-Date23.6%16.0%7.7%
1-Week3.9%3.8%0.1%
1-Month11.4%3.1%8.3%
1-Year-15.1%29.0%-44.1%
3-Year-60.3%65.6%-125.9%
5-Year-60.3%112.6%-172.9%
More...
International Peers - Bayer AG
Company NameCtryMarket
Cap.
last (mUSD)
Bayer AGDEU-0.00
International Peers Median0.75
BASF SEDEU-0.00
GlaxoSmithKline plcGBR74 288
SanofiFRA-0.00
Eli Lilly and CompanyUSA781 875
Novartis AGCHE-0.00
GPRV Analysis
Created with Highcharts 4.1.70/102/104/106/108/1010/10
Bayer AG
Intl. Peers
U.S Patents No. 7,882,001 & 8,082,201
More...
Net Sales Chart
Created with Highcharts 4.1.7Millions EUR201920202021202220232024 (e)2025 (e)2026 (e)2027 (e)0k25k50k75k
More...
Quotes Chart

1-Year Rebased Stock Chart

  • Bayer AG
  • DAX 40
Created with Highcharts 4.1.7Jan '25May '24Sep '24May '25-50%-25%0%25%50%
More...

Did you know ?

Multiples charts provide an effective way to quickly analyze a company's valuation over a period of time, and compare it against the valuation of another company, a personal list, or a market index.

About Market Multiples

Many methods can be used to value a company. In reality, business valuation is often a combination of these different approaches. One of the most widely used quantitative methods is the market multiples method. The market valuation is utilized generally as a primary market input, to provide an objective starting point for the valuation. Put simply, this method multiplies the sales or profits of a business by an industry averaged multiplier to calculate the Market Value of the business.
Current multiples include:
- Historical multiples based on standardized financials for the last completed fiscal period: Last, Last Twelve Months (LTM);
- Forward multiples based on consensus estimates for the current fiscal period and next ones: Next Twelve Months (NTM), FY0, FY1.
Current multiples based on per-share metrics (such as earnings per share or book value per share) are calculated using the last closing price, while current multiples based on company-level metrics (such as net sales, EBIT or EBITDA) are calculated using the current market cap or EV (Enterprise Value).